Annual CFI
-$58.81 M
+$34.18 M+36.76%
31 December 2023
Summary:
Novavax annual cash flow from investing activities is currently -$58.81 million, with the most recent change of +$34.18 million (+36.76%) on 31 December 2023. During the last 3 years, it has risen by +$318.97 million (+84.43%). NVAX annual CFI is now -158.72% below its all-time high of $100.15 million, reached on 31 December 2021.NVAX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$31.91 M
+$404.62 M+108.56%
30 September 2024
Summary:
Novavax quarterly cash flow from investing activities is currently $31.91 million, with the most recent change of +$404.62 million (+108.56%) on 30 September 2024. Over the past year, it has increased by +$50.30 million (+273.52%). NVAX quarterly CFI is now -77.46% below its all-time high of $141.61 million, reached on 31 March 2021.NVAX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$357.12 M
+$50.30 M+12.35%
30 September 2024
Summary:
Novavax TTM cash flow from investing activities is currently -$357.12 million, with the most recent change of +$50.30 million (+12.35%) on 30 September 2024. Over the past year, it has dropped by -$285.33 million (-397.44%). NVAX TTM CFI is now -307.42% below its all-time high of $172.17 million, reached on 31 March 2017.NVAX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVAX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.8% | +273.5% | -397.4% |
| 3 y3 years | +84.4% | +361.8% | -518.2% |
| 5 y5 years | -305.6% | +77.6% | -510.4% |
NVAX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -158.7% | +84.4% | at high | +108.6% | -456.6% | +12.3% |
| 5 y | 5 years | -158.7% | +84.4% | -77.5% | +108.6% | -456.6% | +12.3% |
| alltime | all time | -158.7% | +84.4% | -77.5% | +108.6% | -307.4% | +12.3% |
Novavax Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $31.91 M(-108.6%) | -$357.12 M(-12.3%) |
| June 2024 | - | -$372.71 M(+5040.8%) | -$407.43 M(+858.7%) |
| Mar 2024 | - | -$7.25 M(-20.1%) | -$42.50 M(-27.7%) |
| Dec 2023 | -$58.81 M(-36.8%) | -$9.08 M(-50.6%) | -$58.81 M(-18.1%) |
| Sept 2023 | - | -$18.39 M(+136.4%) | -$71.79 M(-13.4%) |
| June 2023 | - | -$7.78 M(-67.0%) | -$82.92 M(-16.8%) |
| Mar 2023 | - | -$23.56 M(+6.8%) | -$99.72 M(+7.2%) |
| Dec 2022 | -$92.98 M(-192.8%) | -$22.06 M(-25.3%) | -$92.98 M(+6.5%) |
| Sept 2022 | - | -$29.52 M(+20.1%) | -$87.28 M(+24.8%) |
| June 2022 | - | -$24.58 M(+46.1%) | -$69.96 M(+20.0%) |
| Mar 2022 | - | -$16.83 M(+2.8%) | -$58.28 M(-158.2%) |
| Dec 2021 | $100.15 M(-126.5%) | -$16.36 M(+34.2%) | $100.15 M(+17.3%) |
| Sept 2021 | - | -$12.19 M(-5.5%) | $85.40 M(-2833.5%) |
| June 2021 | - | -$12.90 M(-109.1%) | -$3.12 M(-98.2%) |
| Mar 2021 | - | $141.61 M(-555.0%) | -$178.44 M(-52.8%) |
| Dec 2020 | -$377.78 M(-1081.4%) | -$31.12 M(-69.1%) | -$377.78 M(+8.9%) |
| Sept 2020 | - | -$100.71 M(-46.5%) | -$346.87 M(+52.0%) |
| June 2020 | - | -$188.22 M(+226.0%) | -$228.19 M(+501.3%) |
| Mar 2020 | - | -$57.73 M(>+9900.0%) | -$37.95 M(-198.6%) |
| Dec 2019 | $38.49 M(+34.6%) | -$216.00 K(-101.2%) | $38.49 M(-55.8%) |
| Sept 2019 | - | $17.97 M(+788.0%) | $87.03 M(+12.9%) |
| June 2019 | - | $2.02 M(-89.2%) | $77.05 M(+188.4%) |
| Mar 2019 | - | $18.71 M(-61.3%) | $26.72 M(-6.6%) |
| Dec 2018 | $28.60 M(-20.5%) | $48.32 M(+504.3%) | $28.60 M(-1066.4%) |
| Sept 2018 | - | $8.00 M(-116.6%) | -$2.96 M(-109.5%) |
| June 2018 | - | -$48.30 M(-334.6%) | $31.00 M(-62.1%) |
| Mar 2018 | - | $20.59 M(+22.8%) | $81.84 M(+127.5%) |
| Dec 2017 | $35.97 M(+28.4%) | $16.76 M(-60.0%) | $35.97 M(-65.8%) |
| Sept 2017 | - | $41.96 M(+1557.8%) | $105.11 M(-32.5%) |
| June 2017 | - | $2.53 M(-110.0%) | $155.72 M(-9.6%) |
| Mar 2017 | - | -$25.28 M(-129.4%) | $172.17 M(+514.5%) |
| Dec 2016 | $28.02 M(-231.7%) | $85.91 M(-7.2%) | $28.02 M(-158.0%) |
| Sept 2016 | - | $92.57 M(+387.7%) | -$48.33 M(-67.8%) |
| June 2016 | - | $18.98 M(-111.2%) | -$150.11 M(-28.0%) |
| Mar 2016 | - | -$169.44 M(-1872.6%) | -$208.50 M(+880.2%) |
| Dec 2015 | -$21.27 M(-83.6%) | $9.56 M(-203.8%) | -$21.27 M(+57.8%) |
| Sept 2015 | - | -$9.21 M(-76.6%) | -$13.48 M(-76.9%) |
| June 2015 | - | -$39.41 M(-321.5%) | -$58.37 M(-52.1%) |
| Mar 2015 | - | $17.79 M(+2.5%) | -$121.75 M(-6.2%) |
| Dec 2014 | -$129.83 M(-892.1%) | $17.35 M(-132.1%) | -$129.83 M(-5.9%) |
| Sept 2014 | - | -$54.10 M(-47.4%) | -$138.02 M(+101.5%) |
| June 2014 | - | -$102.78 M(-1159.5%) | -$68.51 M(-320.5%) |
| Mar 2014 | - | $9.70 M(+5.9%) | $31.07 M(+89.5%) |
| Dec 2013 | $16.39 M(-150.8%) | $9.16 M(-40.6%) | $16.39 M(-265.8%) |
| Sept 2013 | - | $15.41 M(-580.6%) | -$9.88 M(-69.7%) |
| June 2013 | - | -$3.21 M(-35.5%) | -$32.65 M(-3.9%) |
| Mar 2013 | - | -$4.97 M(-70.9%) | -$33.97 M(+5.3%) |
| Dec 2012 | -$32.26 M(-274.0%) | -$17.11 M(+132.9%) | -$32.26 M(+124.9%) |
| Sept 2012 | - | -$7.35 M(+62.3%) | -$14.34 M(+325.6%) |
| June 2012 | - | -$4.53 M(+38.5%) | -$3.37 M(-146.2%) |
| Mar 2012 | - | -$3.27 M(-506.7%) | $7.29 M(-60.7%) |
| Dec 2011 | $18.54 M(-187.2%) | $804.00 K(-77.8%) | $18.54 M(+28.5%) |
| Sept 2011 | - | $3.62 M(-40.9%) | $14.44 M(+110.6%) |
| June 2011 | - | $6.13 M(-23.2%) | $6.85 M(+341.6%) |
| Mar 2011 | - | $7.99 M(-341.7%) | $1.55 M(-107.3%) |
| Dec 2010 | -$21.27 M | -$3.30 M(-16.5%) | -$21.27 M(+19.2%) |
| Sept 2010 | - | -$3.96 M(-577.4%) | -$17.84 M(+53.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | $829.00 K(-105.6%) | -$11.62 M(-7.4%) |
| Mar 2010 | - | -$14.84 M(<-9900.0%) | -$12.55 M(-633.0%) |
| Dec 2009 | $2.35 M(-92.1%) | $129.00 K(-94.3%) | $2.35 M(-317.9%) |
| Sept 2009 | - | $2.26 M(-2275.0%) | -$1.08 M(-138.0%) |
| June 2009 | - | -$104.00 K(-252.9%) | $2.84 M(-80.2%) |
| Mar 2009 | - | $68.00 K(-102.1%) | $14.38 M(-51.9%) |
| Dec 2008 | $29.91 M(+21.3%) | -$3.31 M(-153.5%) | $29.91 M(+9.8%) |
| Sept 2008 | - | $6.19 M(-45.9%) | $27.24 M(-29.5%) |
| June 2008 | - | $11.43 M(-26.7%) | $38.63 M(+15.2%) |
| Mar 2008 | - | $15.60 M(-361.1%) | $33.52 M(+36.0%) |
| Dec 2007 | $24.65 M(-136.9%) | -$5.97 M(-134.0%) | $24.65 M(+35.0%) |
| Sept 2007 | - | $17.58 M(+178.2%) | $18.26 M(-134.4%) |
| June 2007 | - | $6.32 M(-6.1%) | -$53.11 M(-11.3%) |
| Mar 2007 | - | $6.73 M(-154.4%) | -$59.86 M(-10.4%) |
| Dec 2006 | -$66.81 M(>+9900.0%) | -$12.37 M(-77.0%) | -$66.81 M(+22.6%) |
| Sept 2006 | - | -$53.79 M(>+9900.0%) | -$54.51 M(+7295.8%) |
| June 2006 | - | -$428.00 K(+88.5%) | -$737.00 K(+93.4%) |
| Mar 2006 | - | -$227.00 K(+284.7%) | -$381.00 K(+135.2%) |
| Dec 2005 | -$162.00 K(-89.9%) | -$59.00 K(+156.5%) | -$162.00 K(-43.0%) |
| Sept 2005 | - | -$23.00 K(-68.1%) | -$284.00 K(-63.9%) |
| June 2005 | - | -$72.00 K(+800.0%) | -$786.00 K(-23.6%) |
| Mar 2005 | - | -$8000.00(-95.6%) | -$1.03 M(-36.0%) |
| Dec 2004 | -$1.61 M(-16.2%) | -$181.00 K(-65.5%) | -$1.61 M(-31.4%) |
| Sept 2004 | - | -$525.00 K(+66.7%) | -$2.34 M(-2.4%) |
| June 2004 | - | -$315.00 K(-46.3%) | -$2.40 M(+22.3%) |
| Mar 2004 | - | -$587.00 K(-35.9%) | -$1.96 M(+2.3%) |
| Dec 2003 | -$1.92 M(-80.1%) | -$916.00 K(+57.1%) | -$1.92 M(+1.1%) |
| Sept 2003 | - | -$583.00 K(-574.0%) | -$1.90 M(-48.9%) |
| June 2003 | - | $123.00 K(-122.7%) | -$3.71 M(-51.7%) |
| Mar 2003 | - | -$542.00 K(-39.4%) | -$7.69 M(-20.4%) |
| Dec 2002 | -$9.66 M(+70.5%) | -$895.00 K(-62.7%) | -$9.66 M(-6.1%) |
| Sept 2002 | - | -$2.40 M(-37.6%) | -$10.29 M(+28.3%) |
| June 2002 | - | -$3.85 M(+52.9%) | -$8.02 M(+77.4%) |
| Mar 2002 | - | -$2.52 M(+65.3%) | -$4.52 M(-20.2%) |
| Dec 2001 | -$5.67 M(-57.7%) | -$1.52 M(+1062.6%) | -$5.67 M(-66.4%) |
| Sept 2001 | - | -$131.00 K(-62.6%) | -$16.84 M(-0.2%) |
| June 2001 | - | -$350.00 K(-90.4%) | -$16.87 M(-0.2%) |
| Mar 2001 | - | -$3.66 M(-71.2%) | -$16.90 M(+26.3%) |
| Dec 2000 | -$13.38 M(+1572.9%) | -$12.70 M(+7987.9%) | -$13.38 M(+1604.8%) |
| Sept 2000 | - | -$157.00 K(-59.3%) | -$785.00 K(-36.1%) |
| June 2000 | - | -$386.00 K(+171.8%) | -$1.23 M(+45.8%) |
| Mar 2000 | - | -$142.00 K(+42.0%) | -$842.00 K(+5.3%) |
| Dec 1999 | -$800.00 K(+100.0%) | -$100.00 K(-83.3%) | -$800.00 K(0.0%) |
| Sept 1999 | - | -$600.00 K(<-9900.0%) | -$800.00 K(+166.7%) |
| June 1999 | - | $0.00(-100.0%) | -$300.00 K(-25.0%) |
| Mar 1999 | - | -$100.00 K(0.0%) | -$400.00 K(0.0%) |
| Dec 1998 | -$400.00 K(-233.3%) | -$100.00 K(0.0%) | -$400.00 K(+33.3%) |
| Sept 1998 | - | -$100.00 K(0.0%) | -$300.00 K(+50.0%) |
| June 1998 | - | -$100.00 K(0.0%) | -$200.00 K(0.0%) |
| Mar 1998 | - | -$100.00 K(<-9900.0%) | -$200.00 K(-166.7%) |
| Dec 1997 | $300.00 K(-137.5%) | $0.00(0.0%) | $300.00 K(-250.0%) |
| Sept 1997 | - | $0.00(-100.0%) | -$200.00 K(-33.3%) |
| June 1997 | - | -$100.00 K(-125.0%) | -$300.00 K(0.0%) |
| Mar 1997 | - | $400.00 K(-180.0%) | -$300.00 K(-62.5%) |
| Dec 1996 | -$800.00 K | -$500.00 K(+400.0%) | -$800.00 K(+166.7%) |
| Sept 1996 | - | -$100.00 K(0.0%) | -$300.00 K(+50.0%) |
| June 1996 | - | -$100.00 K(0.0%) | -$200.00 K(+100.0%) |
| Mar 1996 | - | -$100.00 K | -$100.00 K |
FAQ
- What is Novavax annual cash flow from investing activities?
- What is the all time high annual CFI for Novavax?
- What is Novavax annual CFI year-on-year change?
- What is Novavax quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Novavax?
- What is Novavax quarterly CFI year-on-year change?
- What is Novavax TTM cash flow from investing activities?
- What is the all time high TTM CFI for Novavax?
- What is Novavax TTM CFI year-on-year change?
What is Novavax annual cash flow from investing activities?
The current annual CFI of NVAX is -$58.81 M
What is the all time high annual CFI for Novavax?
Novavax all-time high annual cash flow from investing activities is $100.15 M
What is Novavax annual CFI year-on-year change?
Over the past year, NVAX annual cash flow from investing activities has changed by +$34.18 M (+36.76%)
What is Novavax quarterly cash flow from investing activities?
The current quarterly CFI of NVAX is $31.91 M
What is the all time high quarterly CFI for Novavax?
Novavax all-time high quarterly cash flow from investing activities is $141.61 M
What is Novavax quarterly CFI year-on-year change?
Over the past year, NVAX quarterly cash flow from investing activities has changed by +$50.30 M (+273.52%)
What is Novavax TTM cash flow from investing activities?
The current TTM CFI of NVAX is -$357.12 M
What is the all time high TTM CFI for Novavax?
Novavax all-time high TTM cash flow from investing activities is $172.17 M
What is Novavax TTM CFI year-on-year change?
Over the past year, NVAX TTM cash flow from investing activities has changed by -$285.33 M (-397.44%)